Drug
Cyb003
Cyb003: highest development phase Phase 3, developed by Cybin IRL Limited. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Cybin IRL Limited
Trials
| Drug | Phase | Indication |
|---|---|---|
| CYB003 NCT06793397 | Phase 3 | Major Depressive Disorder (MDD) |
Latest
No recent events.
Follow Cyb003 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.